Results 111 to 120 of about 49,369 (250)

Guiding Management of Bethesda V Thyroid Nodules: The Role of Molecular Testing

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective The 2023 Bethesda System update introduced molecular testing as a management option for Bethesda V cytology nodules, aiming to guide surgical decision‐making. This study investigates the correlation between molecular profiling and malignancy aggressiveness. Design We conducted a retrospective multicenter study involving patients with
Idit Tessler   +7 more
wiley   +1 more source

Surgical Outcomes Following Neoadjuvant‐Targeted Therapy for Advanced Differentiated Thyroid Cancer—Real‐World Data

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Background Differentiated thyroid carcinoma (DTC) is typically managed surgically with favourable outcomes. However, surgery may have dire consequences when the tumour invades critical structures. Neoadjuvant therapy with tyrosine kinase inhibitors (TKIs) has emerged as a potential strategy to improve resectability and reduce morbidity in ...
Alexandra Dorman   +15 more
wiley   +1 more source

Pre-ablative Diagnostic Whole-body Scan Following Total Thyroidectomy for Well-differentiated Thyroid Cancer: Is It Necessary?

open access: yesAsian Journal of Surgery, 2005
This study reviewed the incidence of positive pre-ablative diagnostic scan after total thyroidectomy and the efficacy of the current ablative dose. The predictive factors for outcome using a standard ablative dose and postoperative complications of total
Choon Meng Teoh   +3 more
doaj   +1 more source

Identification of BCL2L11 as a Candidate Gene for Hereditary Predisposition to Non‐Medullary Thyroid Cancer Using Familial Whole‐Exome‐Sequencing

open access: yesClinical Genetics, EarlyView.
Whole‐exome sequencing of five families with non‐medullary thyroid cancer revealed three candidate genes. Functional analyses confirmed BCL2L11 as a strong candidate gene for hereditary predisposition to non‐medullary thyroid cancer. ABSTRACT Familial non‐medullary thyroid cancer, defined as two or more affected first‐degree relatives, accounts for 3 ...
Duygu Abbasoglu   +9 more
wiley   +1 more source

Development and Validation of a Prognostic Model for Persistent Hypoparathyroidism After Total or Completion Thyroidectomy

open access: yesClinical Otolaryngology, EarlyView.
ABSTRACT Background The aim of this study was to develop and validate a clinical prediction model to predict the occurrence of persistent hypoparathyroidism after total or completion thyroidectomy. Methods This multicentre retrospective cohort study included patients who underwent total or completion thyroidectomy between January 2010 and June 2021 in ...
Sam P. J. van Dijk   +29 more
wiley   +1 more source

Tracheomalacia: A Rare Complication After Thyroi dectomy

open access: yesIndian Journal of Anaesthesia, 2008
Tracheomalacia is weakness of tracheal wall caused by softening of supporting cartilage and hypotonia of myoelastic elements. In patients with huge thyroid, following thyroidectomy it is due to extrinsic compression by enlarged thyroid in which ...
Dushyant Tripathi, Indira Kumari
doaj  

Biochemical and haemostatic variables associated with metastasis in dogs with carcinoma or sarcoma

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives Identify alterations in biochemical and haemostatic variables between tumour‐bearing dogs with and without metastasis that can be used to predict the presence of metastasis. Materials and Methods Thirty dogs with sarcoma and 29 with carcinoma were included in the analysis.
P. Pazzi   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy